Low Dose of Diltiazem for Rate Control of Atrial Fibrillation

Phase 4

• Conditions: Atrial Fibrillation
• Interventions: Drug: low dose diltiazem

• Registration Number: NCT00834925
• Lead Sponsor: Seoul National University Hospital

Brief Summary

This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of diltiazem(0.25mg/kg) with low dose diltiazem(0.1mg/kg)in atrial fibrillation with rapid ventricular response in ED.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-02-01
• Study First Submitted QC: 2009-02-02
• Study First Posted: 2009-02-03
• Study Start: 2009-08
• Primary Completion: 2009-08
• Status Verified: 2011-07
• Last Update Submitted: 2011-07-25
• Last Update Posted: 2011-07-26
• Study Completion: 2011-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 380

Inclusion Criteria

• atrial fibrillation with rapid ventricular response in emergency room

Exclusion Criteria

• age<18
• systolic blood pressure<90mmHg
• no consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
low dose diltiazem	low dose diltiazem	-

Primary Outcome Measures

Name	Time	Method
Success rate of rate control	in 30 minutes

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of